A nondiagnostic genomic test is a statement about the data, methods and knowledge available at a particular time. Reanalysis revisits existing data in light of changes to those inputs. It can identify a previously unrecognized diagnosis, but it can also weaken an earlier interpretation. Its purpose is better accuracy, not simply accumulating positive results.
Specify what will change
Reanalysis can mean updated annotation, new prioritization rules, additional variant classes, or renewed assessment of previously reported variants. These are not interchangeable. The Australian services study published in 2024 found substantial unmet need and identified workforce capacity as an important barrier. Its findings show why offering reanalysis requires decisions about staffing, funding and responsibility, as well as technical infrastructure. Read the service-delivery study.
A new clinical feature can be as important as a new database entry. Services benefit from an accessible route for clinicians to supply updated phenotype information and family history. Without that route, the analysis can become technically current while the case description remains outdated.
Understand what automation contributes
The Talos study, published in June 2026, evaluated automated prioritization using updated gene and variant evidence. In its cohort of 4,735 previously undiagnosed individuals, the approach identified 241 diagnoses. The authors explicitly describe this yield as cohort dependent. The result supports scalable prioritization; it does not mean that software-generated candidates should automatically become clinical diagnoses. Read the Talos study.
A practical workflow separates candidate generation, expert interpretation, any required validation and communication. Track the number of cases reviewed, the candidates generated, the diagnoses confirmed and the results successfully returned. Otherwise, a promising computational yield can conceal a backlog between discovery and patient benefit.
Plan the return pathway
- Record who can request reanalysis and what triggers it.
- Preserve the original report and the evidence behind a changed conclusion.
- Define who receives a revised report and how contact information is maintained.
- Explain the limits of data retention, consent and future service availability.
No single interval fits every indication or service. New phenotype information or a major analytic advance may justify earlier review, while routine cycles depend on resources and policy. A reanalysis program is most useful when its responsibilities are as explicit as its algorithms.